Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer: Advanced Disease
Join James Stevenson, MD, and Sanjay Mukhopadhyay, MD, from Cleveland Clinic Taussig Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to advanced lung cancer.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer: Early Stage Disease
Join Bill Loo, MD, PhD and Natalie Lui, MD from Stanford Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to early stage lung cancer.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - Non–Small Cell Lung Cancer, Version 5.2018
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added.
Category
  • Lung Cancers
Format
  • Monograph/Journal Supplement
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Stage III NSCLC: Practical Application of Immune Checkpoint Inhibition After Chemoradiotherapy
The goal of this activity is to improve participants’ knowledge of and competence in applying immune checkpoint inhibitors in the treatment of patients with stage III NSCLC.Jointly provided by NCCN and Clinical Care Options, LLC.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Updates: Targeted Therapy for Patients with Metastatic Non-Small Cell Lung Cancer
This information was originally presented at the NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care held in Orlando, Florida, from March 22 - 24, 2018.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: The Evolving Landscape of Immunotherapy and Targeted Therapy for Non-Small Cell Lung Cancer
Join Sally Barbour, PharmD, BCOP, CPP, FHOPA, from Duke Cancer Institute for this webinar in the 2018 NCCN Pharmacy Update Series on the topic The Evolving Landscape of Immunotherapy and Targeted Therapy for Non-Small Cell Lung Cancer.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - Small Cell Lung Cancer, Version 2.2018
The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease management. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for SCLC regarding immunotherapy, systemic therapy, and radiation therapy.
Category
  • Lung Cancers
Format
  • Monograph/Journal Supplement
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Non-Small Cell Lung Cancer
Novel Targeted Therapies and Immunotherapies for Metastatic Non-small Cell Lung Cancer (NSCLC)
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation